CLDX logo

Celldex Therapeutics (CLDX) Depreciation and amortization

annual D&A:

$3.18M+$169.00K(+5.62%)
December 31, 2024

Summary

  • As of today (July 3, 2025), CLDX annual depreciation & amortization is $3.18 million, with the most recent change of +$169.00 thousand (+5.62%) on December 31, 2024.
  • During the last 3 years, CLDX annual D&A has risen by +$109.00 thousand (+3.55%).
  • CLDX annual D&A is now -45.79% below its all-time high of $5.86 million, reached on December 31, 2010.

Performance

CLDX Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXincome statement metrics

quarterly D&A:

$867.00K+$48.00K(+5.86%)
March 31, 2025

Summary

  • As of today (July 3, 2025), CLDX quarterly depreciation & amortization is $867.00 thousand, with the most recent change of +$48.00 thousand (+5.86%) on March 31, 2025.
  • Over the past year, CLDX quarterly D&A has increased by +$92.00 thousand (+11.87%).
  • CLDX quarterly D&A is now -64.29% below its all-time high of $2.43 million, reached on March 31, 2010.

Performance

CLDX quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXincome statement metrics

TTM D&A:

$3.27M+$92.00K(+2.90%)
March 31, 2025

Summary

  • As of today (July 3, 2025), CLDX TTM depreciation & amortization is $3.27 million, with the most recent change of +$92.00 thousand (+2.90%) on March 31, 2025.
  • Over the past year, CLDX TTM D&A has increased by +$212.00 thousand (+6.93%).
  • CLDX TTM D&A is now -46.75% below its all-time high of $6.14 million, reached on September 30, 2010.

Performance

CLDX TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXincome statement metrics

CLDX Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.6%+11.9%+6.9%
3 y3 years+3.5%+6.9%+5.3%
5 y5 years-34.6%-25.6%-29.9%

CLDX Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+9.7%at high+29.2%at high+16.3%
5 y5-year-34.6%+9.7%-24.5%+29.2%-29.9%+16.3%
alltimeall time-45.8%+694.3%-64.3%+240.0%-46.8%>+9999.0%

CLDX Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$867.00K(+5.9%)
$3.27M(+2.9%)
Dec 2024
$3.18M(+5.6%)
$819.00K(+4.2%)
$3.18M(+1.9%)
Sep 2024
-
$786.00K(-1.4%)
$3.12M(+0.6%)
Jun 2024
-
$797.00K(+2.8%)
$3.10M(+1.3%)
Mar 2024
-
$775.00K(+2.1%)
$3.06M(+1.6%)
Dec 2023
$3.01M(+3.9%)
$759.00K(-1.0%)
$3.01M(+2.9%)
Sep 2023
-
$767.00K(+1.5%)
$2.92M(+3.4%)
Jun 2023
-
$756.00K(+4.1%)
$2.83M(+0.5%)
Mar 2023
-
$726.00K(+7.9%)
$2.81M(-2.9%)
Dec 2022
$2.90M(-5.6%)
$673.00K(+0.3%)
$2.90M(-3.5%)
Sep 2022
-
$671.00K(-9.4%)
$3.00M(-2.6%)
Jun 2022
-
$741.00K(-8.6%)
$3.08M(-0.7%)
Mar 2022
-
$811.00K(+4.4%)
$3.10M(+1.2%)
Dec 2021
$3.07M(-21.9%)
$777.00K(+3.3%)
$3.07M(+0.7%)
Sep 2021
-
$752.00K(-1.6%)
$3.05M(-3.5%)
Jun 2021
-
$764.00K(-1.4%)
$3.15M(-10.9%)
Mar 2021
-
$775.00K(+2.6%)
$3.54M(-9.9%)
Dec 2020
$3.93M(-19.1%)
$755.00K(-12.3%)
$3.93M(-9.0%)
Sep 2020
-
$861.00K(-25.0%)
$4.32M(-7.4%)
Jun 2020
-
$1.15M(-1.5%)
$4.67M(-0.1%)
Mar 2020
-
$1.17M(+1.7%)
$4.67M(-3.8%)
Dec 2019
$4.86M(+27.8%)
$1.15M(-5.2%)
$4.86M(+9.6%)
Sep 2019
-
$1.21M(+4.8%)
$4.43M(+9.2%)
Jun 2019
-
$1.15M(-14.7%)
$4.06M(+4.1%)
Mar 2019
-
$1.35M(+87.5%)
$3.90M(+2.6%)
Dec 2018
$3.80M(-28.4%)
$721.00K(-13.7%)
$3.80M(-12.1%)
Sep 2018
-
$835.00K(-15.9%)
$4.33M(-8.7%)
Jun 2018
-
$993.00K(-20.7%)
$4.74M(-4.7%)
Mar 2018
-
$1.25M(+0.5%)
$4.97M(-6.4%)
Dec 2017
$5.31M(+29.8%)
$1.25M(-0.2%)
$5.31M(+0.9%)
Sep 2017
-
$1.25M(+2.0%)
$5.26M(+5.9%)
Jun 2017
-
$1.23M(-23.0%)
$4.97M(+6.0%)
Mar 2017
-
$1.59M(+32.8%)
$4.69M(+14.5%)
Dec 2016
$4.09M(+2.0%)
$1.20M(+25.5%)
$4.09M(+2.4%)
Sep 2016
-
$954.00K(+0.8%)
$4.00M(-1.6%)
Jun 2016
-
$946.00K(-4.9%)
$4.06M(-0.5%)
Mar 2016
-
$995.00K(-9.5%)
$4.08M(+1.7%)
Dec 2015
$4.01M(+17.9%)
$1.10M(+7.8%)
$4.01M(+5.9%)
Sep 2015
-
$1.02M(+5.6%)
$3.79M(+4.5%)
Jun 2015
-
$966.00K(+4.4%)
$3.62M(+3.7%)
Mar 2015
-
$925.00K(+5.5%)
$3.49M(+2.7%)
Dec 2014
$3.40M(+15.5%)
$877.00K(+2.5%)
$3.40M(+3.5%)
Sep 2014
-
$856.00K(+2.4%)
$3.29M(+3.9%)
Jun 2014
-
$836.00K(+0.5%)
$3.16M(+3.5%)
Mar 2014
-
$832.00K(+9.0%)
$3.06M(+3.8%)
Dec 2013
$2.94M(-6.1%)
$763.00K(+4.2%)
$2.94M(+1.3%)
Sep 2013
-
$732.00K(+0.4%)
$2.91M(-0.8%)
Jun 2013
-
$729.00K(+1.1%)
$2.93M(-3.0%)
Mar 2013
-
$721.00K(-0.6%)
$3.02M(-3.6%)
Dec 2012
$3.14M(-24.6%)
$725.00K(-4.1%)
$3.14M(-3.6%)
Sep 2012
-
$756.00K(-7.9%)
$3.25M(-12.5%)
Jun 2012
-
$821.00K(-1.7%)
$3.72M(-5.8%)
Mar 2012
-
$835.00K(-0.9%)
$3.95M(-5.0%)
Dec 2011
$4.16M(-29.0%)
$843.00K(-31.0%)
$4.16M(-3.9%)
Sep 2011
-
$1.22M(+16.3%)
$4.33M(+3.8%)
Jun 2011
-
$1.05M(+0.6%)
$4.17M(-6.9%)
Mar 2011
-
$1.04M(+3.2%)
$4.48M(-23.6%)
Dec 2010
$5.86M(+65.9%)
$1.01M(-4.6%)
$5.86M(-4.5%)
Sep 2010
-
$1.06M(-21.8%)
$6.14M(+6.0%)
Jun 2010
-
$1.36M(-44.1%)
$5.79M(+11.8%)
Mar 2010
-
$2.43M(+88.1%)
$5.18M(+46.6%)
Dec 2009
$3.53M(+39.2%)
$1.29M(+80.8%)
$3.53M(+28.4%)
Sep 2009
-
$714.00K(-4.3%)
$2.75M(-3.5%)
Jun 2009
-
$746.00K(-4.5%)
$2.85M(-2.3%)
Mar 2009
-
$781.00K(+53.3%)
$2.92M(+14.9%)
Dec 2008
$2.54M(+206.7%)
$509.40K(-37.4%)
$2.54M(+14.1%)
Sep 2008
-
$813.40K(+0.2%)
$2.22M(+176.0%)
Jun 2008
-
$812.10K(+102.0%)
$805.40K(-21.0%)
Mar 2008
-
$402.00K(+105.7%)
$1.02M(+23.3%)
Dec 2007
$827.10K
$195.40K(-132.3%)
$827.10K(+6464.3%)
Sep 2007
-
-$604.10K(-158.8%)
$12.60K(-98.9%)
DateAnnualQuarterlyTTM
Jun 2007
-
$1.03M(+391.0%)
$1.16M(+86.2%)
Mar 2007
-
$209.10K(-133.8%)
$622.50K(-29.8%)
Dec 2006
$886.50K(-58.4%)
-$619.10K(-214.2%)
$886.50K(-58.4%)
Sep 2006
-
$542.30K(+10.6%)
$2.13M(-1.6%)
Jun 2006
-
$490.20K(+3.6%)
$2.16M(-4.3%)
Mar 2006
-
$473.10K(-24.2%)
$2.26M(+6.1%)
Dec 2005
$2.13M(+24.1%)
$624.00K(+8.3%)
$2.13M(+8.1%)
Sep 2005
-
$576.40K(-1.8%)
$1.97M(+8.9%)
Jun 2005
-
$586.90K(+71.4%)
$1.81M(+10.5%)
Mar 2005
-
$342.40K(-26.2%)
$1.64M(-4.6%)
Dec 2004
$1.72M(+12.4%)
$464.10K(+11.6%)
$1.72M(+19.2%)
Sep 2004
-
$416.00K(+0.4%)
$1.44M(-2.3%)
Jun 2004
-
$414.40K(-1.7%)
$1.47M(-2.7%)
Mar 2004
-
$421.70K(+125.1%)
$1.51M(-0.9%)
Dec 2003
$1.53M(-5.9%)
$187.30K(-58.4%)
$1.53M(-12.0%)
Sep 2003
-
$449.80K(-1.1%)
$1.73M(+3.1%)
Jun 2003
-
$454.90K(+4.6%)
$1.68M(+3.3%)
Mar 2003
-
$435.10K(+10.2%)
$1.63M(+0.4%)
Dec 2002
$1.62M(-28.1%)
$394.80K(-0.5%)
$1.62M(-11.4%)
Sep 2002
-
$396.90K(-1.0%)
$1.83M(-7.4%)
Jun 2002
-
$401.10K(-6.6%)
$1.98M(-7.8%)
Mar 2002
-
$429.30K(-28.8%)
$2.14M(-5.1%)
Dec 2001
$2.26M(+72.2%)
$603.00K(+11.2%)
$2.26M(+10.4%)
Sep 2001
-
$542.20K(-4.5%)
$2.05M(+13.5%)
Jun 2001
-
$567.70K(+4.3%)
$1.80M(+17.6%)
Mar 2001
-
$544.40K(+39.2%)
$1.53M(+16.9%)
Dec 2000
$1.31M(-34.1%)
$391.00K(+31.0%)
$1.31M(+8.5%)
Sep 2000
-
$298.50K(-0.1%)
$1.21M(-20.0%)
Jun 2000
-
$298.70K(-7.4%)
$1.51M(-11.8%)
Mar 2000
-
$322.60K(+11.8%)
$1.71M(-13.9%)
Dec 1999
$1.99M(+98.9%)
$288.60K(-51.9%)
$1.99M(-13.5%)
Sep 1999
-
$600.00K(+20.0%)
$2.30M(+21.1%)
Jun 1999
-
$500.00K(-16.7%)
$1.90M(+26.7%)
Mar 1999
-
$600.00K(0.0%)
$1.50M(+50.0%)
Dec 1998
$1.00M(+150.0%)
$600.00K(+200.0%)
$1.00M(+100.0%)
Sep 1998
-
$200.00K(+100.0%)
$500.00K(+25.0%)
Jun 1998
-
$100.00K(0.0%)
$400.00K(0.0%)
Mar 1998
-
$100.00K(0.0%)
$400.00K(0.0%)
Dec 1997
$400.00K(-20.0%)
$100.00K(0.0%)
$400.00K(0.0%)
Sep 1997
-
$100.00K(0.0%)
$400.00K(-20.0%)
Jun 1997
-
$100.00K(0.0%)
$500.00K(0.0%)
Mar 1997
-
$100.00K(0.0%)
$500.00K(0.0%)
Dec 1996
$500.00K(-28.6%)
$100.00K(-50.0%)
$500.00K(-28.6%)
Sep 1996
-
$200.00K(+100.0%)
$700.00K(+16.7%)
Jun 1996
-
$100.00K(0.0%)
$600.00K(0.0%)
Mar 1996
-
$100.00K(-66.7%)
$600.00K(-14.3%)
Dec 1995
$700.00K(-12.5%)
$300.00K(+200.0%)
$700.00K(+16.7%)
Sep 1995
-
$100.00K(0.0%)
$600.00K(-14.3%)
Jun 1995
-
$100.00K(-50.0%)
$700.00K(-12.5%)
Mar 1995
-
$200.00K(0.0%)
$800.00K(0.0%)
Dec 1994
$800.00K(-11.1%)
$200.00K(0.0%)
$800.00K(-20.0%)
Sep 1994
-
$200.00K(0.0%)
$1.00M(0.0%)
Jun 1994
-
$200.00K(0.0%)
$1.00M(+11.1%)
Mar 1994
-
$200.00K(-50.0%)
$900.00K(0.0%)
Dec 1993
$900.00K(+50.0%)
$400.00K(+100.0%)
$900.00K(+80.0%)
Sep 1993
-
$200.00K(+100.0%)
$500.00K(-16.7%)
Jun 1993
-
$100.00K(-50.0%)
$600.00K(0.0%)
Mar 1993
-
$200.00K(-33.3%)
$600.00K(-14.3%)
Dec 1992
$600.00K(0.0%)
-
-
Oct 1992
-
$300.00K(+200.0%)
$700.00K(+16.7%)
Jul 1992
-
$100.00K(-50.0%)
$600.00K(0.0%)
Apr 1992
-
$200.00K(+100.0%)
$600.00K(0.0%)
Apr 1992
$600.00K(0.0%)
-
-
Jan 1992
-
$100.00K(-50.0%)
$600.00K(0.0%)
Oct 1991
-
$200.00K(+100.0%)
$600.00K(0.0%)
Jul 1991
-
$100.00K(-50.0%)
$600.00K(0.0%)
Apr 1991
$600.00K(+20.0%)
$200.00K(+100.0%)
$600.00K(+50.0%)
Jan 1991
-
$100.00K(-50.0%)
$400.00K(+33.3%)
Oct 1990
-
$200.00K(+100.0%)
$300.00K(+200.0%)
Jul 1990
-
$100.00K
$100.00K
Apr 1990
$500.00K
-
-

FAQ

  • What is Celldex Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Celldex Therapeutics?
  • What is Celldex Therapeutics annual D&A year-on-year change?
  • What is Celldex Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Celldex Therapeutics?
  • What is Celldex Therapeutics quarterly D&A year-on-year change?
  • What is Celldex Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Celldex Therapeutics?
  • What is Celldex Therapeutics TTM D&A year-on-year change?

What is Celldex Therapeutics annual depreciation & amortization?

The current annual D&A of CLDX is $3.18M

What is the all time high annual D&A for Celldex Therapeutics?

Celldex Therapeutics all-time high annual depreciation & amortization is $5.86M

What is Celldex Therapeutics annual D&A year-on-year change?

Over the past year, CLDX annual depreciation & amortization has changed by +$169.00K (+5.62%)

What is Celldex Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of CLDX is $867.00K

What is the all time high quarterly D&A for Celldex Therapeutics?

Celldex Therapeutics all-time high quarterly depreciation & amortization is $2.43M

What is Celldex Therapeutics quarterly D&A year-on-year change?

Over the past year, CLDX quarterly depreciation & amortization has changed by +$92.00K (+11.87%)

What is Celldex Therapeutics TTM depreciation & amortization?

The current TTM D&A of CLDX is $3.27M

What is the all time high TTM D&A for Celldex Therapeutics?

Celldex Therapeutics all-time high TTM depreciation & amortization is $6.14M

What is Celldex Therapeutics TTM D&A year-on-year change?

Over the past year, CLDX TTM depreciation & amortization has changed by +$212.00K (+6.93%)
On this page